全文获取类型
收费全文 | 52869篇 |
免费 | 4342篇 |
国内免费 | 1607篇 |
专业分类
耳鼻咽喉 | 621篇 |
儿科学 | 639篇 |
妇产科学 | 1092篇 |
基础医学 | 8193篇 |
口腔科学 | 1422篇 |
临床医学 | 4420篇 |
内科学 | 10078篇 |
皮肤病学 | 1017篇 |
神经病学 | 3779篇 |
特种医学 | 1705篇 |
外国民族医学 | 6篇 |
外科学 | 7355篇 |
综合类 | 4095篇 |
现状与发展 | 1篇 |
一般理论 | 5篇 |
预防医学 | 2998篇 |
眼科学 | 1374篇 |
药学 | 4762篇 |
中国医学 | 807篇 |
肿瘤学 | 4449篇 |
出版年
2023年 | 215篇 |
2022年 | 351篇 |
2021年 | 588篇 |
2020年 | 384篇 |
2019年 | 648篇 |
2018年 | 1143篇 |
2017年 | 897篇 |
2016年 | 882篇 |
2015年 | 997篇 |
2014年 | 1321篇 |
2013年 | 1619篇 |
2012年 | 2183篇 |
2011年 | 2119篇 |
2010年 | 1280篇 |
2009年 | 1257篇 |
2008年 | 1858篇 |
2007年 | 1966篇 |
2006年 | 1829篇 |
2005年 | 1505篇 |
2004年 | 1358篇 |
2003年 | 1343篇 |
2002年 | 1280篇 |
2001年 | 4639篇 |
2000年 | 4551篇 |
1999年 | 3917篇 |
1998年 | 1374篇 |
1997年 | 1009篇 |
1996年 | 613篇 |
1995年 | 506篇 |
1994年 | 453篇 |
1993年 | 415篇 |
1992年 | 1934篇 |
1991年 | 1676篇 |
1990年 | 1528篇 |
1989年 | 1489篇 |
1988年 | 1297篇 |
1987年 | 1194篇 |
1986年 | 1063篇 |
1985年 | 900篇 |
1984年 | 588篇 |
1983年 | 467篇 |
1982年 | 249篇 |
1981年 | 180篇 |
1980年 | 141篇 |
1979年 | 280篇 |
1978年 | 77篇 |
1974年 | 75篇 |
1973年 | 95篇 |
1972年 | 71篇 |
1969年 | 66篇 |
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
1.
N. Shor R. Deschamps A. Cobo Calvo E. Maillart H. Zephir J. Ciron C. Papeix F. Durand-Dubief A. Ruet X. Ayrignac M. Cohen K. Deiva D. Laplaud B. Bourre B. Audoin N. Collongues S. Vukusic F. Cotton R. Marignier 《Revue neurologique》2021,177(1-2):39-50
Our knowledge of the radiological spectrum of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is growing rapidly. An update on the radiological features of the disease, and its evolution is thus necessary. Magnetic resonance imaging (MRI) has an increasingly important role in the differential diagnosis of MOGAD particularly from aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and multiple sclerosis (MS). Differentiating these conditions is of prime importance because the management is different between the three inflammatory diseases, and thus could prevent further attack-related disability. Therefore, identifying the MRI features suggestive of MOGAD has diagnostic and prognostic implications. We herein review optic nerve, spinal cord and the brain MRI findings from MOGAD adult patients, and compare them to AQP4-NMOSD and MS. 相似文献
2.
Shulin Wu Sharron X. Lin Gregory J. Wirth Min Lu Jian Lu Alexander O. Subtelny Zongwei Wang Douglas M. Dahl Aria F. Olumi Chin-Lee Wu 《Clinical genitourinary cancer》2019,17(1):e44-e52
Objective
To assess the impact of focality and location of positive surgical margins (PSM) on long-term outcomes after radical prostatectomy (RP) for prostate cancer (PCa), including biochemical recurrence (BCR), metastasis and overall mortality.Patients and Methods
From a total of 2796 cases of RP between 1993 and 2007 in our single hospital, 476 cases with PSMs were identified and included in this study. PSM location was categorized into apex, peripheral, and bladder neck. Survival was estimated using the Kaplan-Meier method. Cox proportional hazard regression models were used to analyze the impact of PSM focality and location status on oncologic survival.Results
Of these 476 cases with PSMs, 335 (70.4%) cases were with single focal (sF) PSMs and 141 (29.6%) cases were with multifocal (mF) PSMs. Furthermore, 406 (85.3%) cases were found to have single location (sL) PSMs, and 70 (14.7%) cases were with multilocation (mL) PSMs. The median follow-up was 12.9 years. mF-PSMs and mL-PSMs showed significant impact on increased BCR risk on univariate analysis, and mL-PSMs remained significant on multivariate analysis (P = .048). Furthermore, the combination of multifocality and multilocation showed added prognostic value on predicting BCR-free survival, but not on metastasis-free survival or overall survival.Conclusion
The presence of mF-PSMs and mL-PSMs, and especially the combination of both, demonstrated significant impact on BCR prognosis. Patients with apex sLsF-PSMs were less likely to have BCR when compared with all those with non-apex sLsF-PSMs. These results should be considered when evaluating patients for adjuvant therapy. 相似文献3.
Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience 下载免费PDF全文
P. Wils Y. Bouhnik P. Michetti B. Flourie H. Brixi A. Bourrier M. Allez B. Duclos M. Serrero A. Buisson A. Amiot M. Fumery X. Roblin L. Peyrin‐Biroulet J. Filippi G. Bouguen V. Abitbol B. Coffin M. Simon D. Laharie B. Pariente Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif 《Alimentary pharmacology & therapeutics》2018,47(5):588-595
4.
5.
Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study 下载免费PDF全文
6.
7.
8.
9.
10.